Study finds aflibercept 8 mg supports 16 weeks intervals for PCV
December 18, 2025

Study Finds Comparable PCV Outcomes with Aflibercept 8 mg at Longer Intervals

Fewer injections, same outcomes? New PULSAR data suggest durability may be catching up in PCV.  In retina care, durability has…

Discover our fascinating content at issuu

explore